Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Trueblue ( (TBI) ) just unveiled an update.
On May 5, 2025, TrueBlue reported its first quarter 2025 financial results, showing a revenue of $370 million, an 8% decrease from the previous year. The company faced a net loss of $14 million, with adjusted EBITDA at -$4 million. Despite subdued market demand and evolving governmental policies impacting the staffing industry, TrueBlue remains focused on leveraging its strengths and strategic priorities to capture market share and enhance profitability. The acquisition of Healthcare Staffing Professionals is part of its expansion into growth markets and high-value roles, including healthcare.
Spark’s Take on TBI Stock
According to Spark, TipRanks’ AI Analyst, TBI is a Neutral.
Trueblue’s overall stock score reflects considerable financial and technical challenges, as evidenced by declining revenues and bearish market indicators. While strategic initiatives and cost management offer some optimism, the significant revenue declines and net losses pose substantial risks. The current valuation and negative earnings further weigh down the stock’s attractiveness.
To see Spark’s full report on TBI stock, click here.
More about Trueblue
TrueBlue (NYSE: TBI) is a company that transforms how organizations connect with talent, offering flexible staffing, workforce management, and recruitment solutions across industries worldwide. Its brands include PeopleReady, PeopleScout, Staff Management | SMX, Centerline, SIMOS, and Healthcare Staffing Professionals.
YTD Price Performance: -43.37%
Average Trading Volume: 240,588
Technical Sentiment Signal: Buy
Current Market Cap: $132.4M
For a thorough assessment of TBI stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue